Sinovac Biotech Ltd (SVA) — Financial Flexibility Index
Sinovac Biotech Ltd (SVA) has a Financial Flexibility Index of 0.12x as of December 2023. Free cash flow of $198.75 Million (operating CF $146.01 Million minus capex $52.75 Million) represents 0% of total liabilities ($1.64 Billion). Check SVA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinovac Biotech Ltd Financial Flexibility Index (2000–2025)
Historical Financial Flexibility Index trend for Sinovac Biotech Ltd across 26 annual periods. For the full cash flow conversion analysis, see SVA cash flow metrics.
Annual Financial Flexibility Index for Sinovac Biotech Ltd (2000–2025)
Year-by-year free cash flow to debt coverage for Sinovac Biotech Ltd. Explore cash flow to debt ratio of Sinovac Biotech Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.21x | $-461.57 Million | $-510.49 Million | $2.23 Billion | ▼ -1138.0% |
| 2024 | 0.02x | $40.70 Million | $-56.89 Million | $2.04 Billion | ▼ -87.1% |
| 2023 | 0.15x | $251.71 Million | $106.02 Million | $1.64 Billion | ▲ +158.7% |
| 2022 | -0.26x | $-367.38 Million | $-770.75 Million | $1.40 Billion | ▼ -104.7% |
| 2021 | 5.60x | $16.07 Billion | $15.35 Billion | $2.87 Billion | ▲ +620.2% |
| 2020 | 0.78x | $606.96 Million | $479.31 Million | $781.20 Million | ▲ +56.5% |
| 2019 | 0.50x | $49.70 Million | $39.07 Million | $100.10 Million | ▲ +185.1% |
| 2018 | 0.17x | $13.56 Million | $7.94 Million | $77.85 Million | ▼ -80.2% |
| 2017 | 0.88x | $71.67 Million | $59.76 Million | $81.69 Million | ▲ +2655.1% |
| 2016 | -0.03x | $-2.81 Million | $-15.46 Million | $81.69 Million | ▼ -124.0% |
| 2015 | 0.14x | $9.51 Million | $4.21 Million | $66.42 Million | ▲ +1663.4% |
| 2014 | 0.01x | $786.00K | $-10.13 Million | $96.80 Million | ▼ -92.6% |
| 2013 | 0.11x | $10.71 Million | $5.58 Million | $97.05 Million | ▲ +9031.7% |
| 2012 | 0.00x | $-98.00K | $-16.25 Million | $79.33 Million | ▼ -100.3% |
| 2011 | 0.42x | $29.39 Million | $13.94 Million | $70.61 Million | ▲ +149.8% |
| 2010 | 0.17x | $11.10 Million | $-14.28 Million | $66.60 Million | ▼ -80.7% |
| 2009 | 0.86x | $52.73 Million | $48.41 Million | $61.01 Million | ▲ +42.1% |
| 2008 | 0.61x | $14.48 Million | $10.50 Million | $23.80 Million | ▲ +120.2% |
| 2007 | 0.28x | $6.78 Million | $4.32 Million | $24.55 Million | ▲ +976.0% |
| 2006 | -0.03x | $-495.31K | $-1.64 Million | $15.70 Million | ▼ -141.6% |
| 2005 | 0.08x | $520.01K | $-1.13 Million | $6.86 Million | ▲ +361.3% |
| 2004 | 0.02x | $112.72K | $-1.54 Million | $6.86 Million | ▲ +106.6% |
| 2003 | -0.25x | $-993.86K | $-1.72 Million | $4.01 Million | ▲ +40.8% |
| 2002 | -0.42x | $-57.25K | $-58.05K | $136.81K | ▲ +18.9% |
| 2001 | -0.52x | $-491.09K | $-494.80K | $952.15K | ▲ +0.0% |
| 2000 | -0.52x | $-491.09K | $-494.80K | $952.15K | — |